The global market for managing EGFR inhibitors induced skin disorders is expanding due to increased awareness and the growing use of EGFR-targeted cancer therapies. These inhibitors, crucial for ...

Medically reviewed by Marla Anderson, MDMedically reviewed by Marla Anderson, MD EGFR-positive lung cancer is a type of lung cancer with an epidermal growth factor receptor (EGFR) mutation. In the ...

The timing of breast cancer recurrence after mastectomy and adjuvant CMF chemotherapy supports a dormancy-based model for metastatic development BACKGROUND: Her2/neu and epidermal growth factor ...

CORONADO, Calif. — Epidermal growth factor receptor (EGFR) is a validated therapeutic target for non-small cell lung cancer. Researchers have now discovered a 93-gene signature that is associated with ...

AUGUSTA, Ga. (April 28, 2022) – About one-fifth of often deadly head and neck cancers harbor genetic mutations in a pathway that is key to normal cell growth, and scientists report those mutations, ...

Mefatinib as first-line treatment of patients with advanced non–small cell lung cancer harboring rare EGFR mutations. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This ...

Yes, cancer is fundamentally a genetic disease, but not only a hereditary one. Most cancers arise from mutations acquired ...

Researchers have combined two gene editing methods. This enables them to quickly investigate the significance of many genetic mutations involved in the development and treatment of cancer. Researchers ...

Researchers at ETH Zurich in Basel report they have used CRISPR-Cas technology to decipher how mutations in a cell’s genome affect its function. With their new approach, the researchers can generate ...